Duke-Coulter Translational Partnership Grant

The Duke-Coulter Translational Partnership Grant sits inside the Duke-Coulter Translational Partnership and funds translational projects jointly led by Duke Biomedical Engineering faculty and Duke School of Medicine clinical faculty. The program is funded from a $20 million Coulter Foundation endowment and is run as a self-sustaining Duke vehicle rather than a direct Wallace H. Coulter Foundation award. Awards range from $40,000 to $330,000 in direct costs, with roughly $700,000 distributed each year across three to five grants. Indirect costs are set at 0%, including subcontracts. Eligibility is internal to Duke and requires at least two co-PIs: one with a primary or secondary BME faculty appointment and one clinical faculty member with access to patients or patient samples. Projects must point toward commercialization or clinical improvement that addresses an unmet clinical need. The selection model is deliberately hands-on, with a Coulter Foundation Oversight Committee and Coulter Program Director involved in review. Awards last one year and must compete again for future support, so the strongest proposals pair a real clinical problem with a credible translational plan, clear teamwork across engineering and medicine, and a path to measurable patient impact.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.